MeiraGTx Holdings (MGTX) EBITDA (2017 - 2025)
MeiraGTx Holdings posted quarterly EBITDA of $23.8 million for Q4 2025, up 162.21% year-on-year from $9.1 million in Q4 2024, and up 148.29% on a QoQ basis from -$49.3 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of EBITDA data on file, last reported at $23.8 million in Q4 2025.
- For the quarter ending Q4 2025, EBITDA rose 162.21% year-over-year to $23.8 million; the trailing twelve-month figure through Dec 2025 stood at -$108.1 million (up 27.99% YoY), and the FY2025 full-year result was -$108.1 million, up 27.99% from the prior year.
- EBITDA for Q4 2025 stood at $23.8 million, up from -$49.3 million in the prior quarter.
- Across five years, EBITDA topped out at $23.8 million in Q4 2025 and bottomed at -$49.3 million in Q3 2025.
- The 5-year median for EBITDA is -$30.6 million (2022), against an average of -$27.4 million.
- The widest annual swing landed in 2024, when EBITDA sank 429.35%; it then jumped 162.21% in 2025.
- A 5-year view of EBITDA shows it stood at -$9.7 million in 2021, then sank by 278.81% to -$36.7 million in 2022, then surged by 131.7% to $11.6 million in 2023, then tumbled by 429.35% to -$38.3 million in 2024, then soared by 162.21% to $23.8 million in 2025.
- The last three EBITDA figures came in at $23.8 million (Q4 2025), -$49.3 million (Q3 2025), and -$41.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 201.19 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 23.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.81 Mn |
| Sep 30, 2025 | -49.30 Mn |
| Jun 30, 2025 | -41.25 Mn |
| Mar 31, 2025 | -41.33 Mn |
| Dec 31, 2024 | -38.27 Mn |
| Sep 30, 2024 | -40.56 Mn |
| Jun 30, 2024 | -49.11 Mn |
| Mar 31, 2024 | -22.13 Mn |
| Dec 31, 2023 | 11.62 Mn |
| Sep 30, 2023 | -38.29 Mn |
| Jun 30, 2023 | -32.12 Mn |
| Mar 31, 2023 | -32.72 Mn |
| Dec 31, 2022 | -36.66 Mn |
| Sep 30, 2022 | -28.51 Mn |
| Jun 30, 2022 | -26.62 Mn |
| Mar 31, 2022 | -29.11 Mn |
| Dec 31, 2021 | -9.68 Mn |
| Sep 30, 2021 | -23.28 Mn |
| Jun 30, 2021 | -20.49 Mn |
| Mar 31, 2021 | -23.89 Mn |
| Dec 31, 2020 | -13.91 Mn |
| Sep 30, 2020 | -10.55 Mn |
| Jun 30, 2020 | -24.90 Mn |
| Mar 31, 2020 | -11.74 Mn |
| Dec 31, 2019 | -9.67 Mn |
| Sep 30, 2019 | -8.81 Mn |
| Jun 30, 2019 | -19.24 Mn |
| Mar 31, 2019 | -19.12 Mn |
| Dec 31, 2018 | -20.47 Mn |
| Sep 30, 2018 | -14.92 Mn |
| Jun 30, 2018 | -28.00 Mn |
| Mar 31, 2018 | -17.16 Mn |
| Dec 31, 2017 | -9.14 Mn |
| Sep 30, 2017 | -8.79 Mn |
| Jun 30, 2017 | -7.52 Mn |